tiprankstipranks
Trending News
More News >
Defence Therapeutics (TSE:DTC)
:DTC
Canadian Market

Defence Therapeutics (DTC) Financial Statements

Compare
10 Followers

Defence Therapeutics Financial Overview

Defence Therapeutics's market cap is currently C$39.40M. The company's EPS TTM is C$; its P/E ratio is -10.17; Defence Therapeutics is scheduled to report earnings on November 27, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -72.34KC$ -90.92KC$ -13.82KC$ 0.00C$ 0.00
Operating IncomeC$ -3.27MC$ -12.66MC$ -6.55MC$ -3.56MC$ -2.86M
EBITDAC$ -3.13MC$ -12.68MC$ -6.48MC$ 0.00C$ 0.00
Net IncomeC$ -3.52MC$ -13.19MC$ -6.76MC$ -7.34MC$ -2.86M
Balance Sheet
Cash & Short-Term InvestmentsC$ 1.23MC$ 56.55KC$ 2.79MC$ 506.70KC$ 5.45M
Total AssetsC$ 1.65MC$ 477.75KC$ 3.53MC$ 719.67KC$ 5.61M
Total DebtC$ 1.50MC$ 1.75MC$ 1.75MC$ 0.00C$ 0.00
Net DebtC$ 271.84KC$ 1.69MC$ -1.05MC$ -506.70KC$ -5.45M
Total LiabilitiesC$ 2.91MC$ 4.06MC$ 1.97MC$ 1.11MC$ 122.26K
Stockholders' EquityC$ -1.26MC$ -3.58MC$ 1.57MC$ -387.56KC$ 5.49M
Cash Flow
Free Cash FlowC$ -3.40MC$ -4.49MC$ -7.72MC$ -6.04MC$ -2.29M
Operating Cash FlowC$ -3.40MC$ -4.29MC$ -7.66MC$ -6.04MC$ -2.29M
Investing Cash FlowC$ 3.60KC$ -203.24KC$ -65.80KC$ 0.00C$ 0.00
Financing Cash FlowC$ 4.57MC$ 1.76MC$ 10.01MC$ 1.10MC$ 5.88M
Currency in CAD

Defence Therapeutics Earnings and Revenue History

Defence Therapeutics Debt to Assets

Defence Therapeutics Cash Flow

Defence Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.